Interleukin-1 gene cluster polymorphisms predict risk of ESRD

Kidney International

Volumn 68, Issue 1, 2005, Pages 278-284

  Wetmore, James B ^c   Hung, Adriana M ^a   Lovett, David H ^d   Sen, Saunak ^d   Quershy, Omer ^b   Johansen, Kirsten L ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE

Author keywords

Dialysis; ESRD; Genotype; Interleukin 1; Interleukin 1 receptor antagonist; Polymorphisms

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; SIALOGLYCOPROTEIN;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENETIC RISK; GENOTYPE; HEMODIALYSIS; HOMOZYGOSITY; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT; AGED; CHRONIC KIDNEY FAILURE; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MULTIGENE FAMILY; PREDICTION AND FORECASTING; RISK FACTOR;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; KIDNEY FAILURE, CHRONIC; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SIALOGLYCOPROTEINS;

EID: 24944455170     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00403.x     Document Type: Article

References (25)

1. SHLIPAK MG, FRIED LF, CRUMP C, et al: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87-92, 2003
2. ERLINGER TP, TARVER-CARR ME, POWE NR, et al: Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. Am J Kidney Dis 42:256-263, 2003
3. NICKLIN MJ, BARTON JL, NGUYEN M, et al: A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 79:718-725, 2002
4. AREND WP, MALYAK M, GUTHRIDGE CJ, GABAY C: Interleukin-1 receptor antagonist: Role in biology. Annu Rev Immunol 16:27-55, 1998
5. DINARELLO CA: Biologic basis for interleukin-1 in disease. Blood 87:2095-2147, 1996
6. COUSSENS LM, FINGLETON B, MATRISIAN LM: Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 295:2387-2392, 2002
7. KORNMAN KS, PANKOW J, OFFENBACHER S, et al: Interleukin-1 genotypes and the association between periodontitis and cardiovascular disease. J Periodontal Res 34:353-357, 1999
8. PESSI T, KARJALAINEN J, HULKKONEN J, et al: A common IL-1 complex haplotype is associated with an increased risk of atopy. J Med Genet 40:e66, 2003
9. PARKS CG, COOPER GS, DOOLEY MA, et al: Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: A population based study in the southeastern United States. Ann Rheum Dis 63:91-94, 2004
10. TSENG LH, CHEN PJ, LIN MT, et al: Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: Further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens 57:318-324, 2001
11. FRANCIS SE, CAMP NJ, DEWBERRY RM, et al: Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99:861-866, 1999
12. TARLOW JK, BLAKEMORE AI, LENNARD A, et al: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91:403-404, 1993
13. BORGMANN S, ENDISCH G, HACKER UT, et al: Proinflammatory genotype of interleukin-1 and interleukin-1 receptor antagonist is associated with ESRD in proteinase 3-ANCA vasculitis patients. Am J Kidney Dis 41:933-942, 2003
14. FREEDMAN BI, YU H, SPRAY BJ, et al: Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney Int 51:819-825, 1997
15. BLAKEMORE AI, COX A, GONZALEZ AM, et al: Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 97:369-374, 1996
16. LOUGHREY BV, MAXWELL AP, FOGARTY DG, et al: An interleukin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine 10:984-988, 1998
17. HURME M, SANTTILA S: IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 28:2598-2602, 1998
18. BENSEN JT, LANGEFELD CD, HAWKINS GA, et al: Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster. Genomics 82:194-217, 2003
19. SCHAID DJ, ROWLAND CM, TINES DE, et al: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434, 2002
20. NELDER JA: A large class of models derived from generalized linear models. Stat Med 17:2747-2753, 1998
21. AKAIKE H: Information theory and an extension of the maximum likelihood principle, in Proceedings of the Second International Symposium on Information Theory, edited by Petrov BN, Caski F, Budapest, Akademiai Kiado, 1973, pp 267-281
22. NIELSEN DM, EHM MG, ZAYKIN DV, et al: Effect of two-and three-locus linkage disequilibrium on the power to detect marker/phenotype associations. Genetics 168:1029-1040, 2004
23. SHU KH, LEE SH, CHENG CH, et al: Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 58:783-789, 2000
24. DEWBERRY RM, CROSSMAN DC, FRANCIS SE: Interleukin-1 receptor antagonist (IL-1RN) genotype modulates the replicative capacity of human endothelial cells. Circ Res 92:1285-1287, 2003
25. DEWBERRY R, HOLDEN H, CROSSMAN D, FRANCIS S: Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol 20:2394-2400, 2000